Cardiac surgery

Our cardiac surgery destination for education, evidence, and innovation. We update our information and features frequently. Check back for upcoming physician news and stories.

New cardiac surgery podcast — The Cardiac Exchange

Listen. Learn. Connect. And be inspired.

Medical education


Dr. Bolling reflects on mitral valve repair wet labs at his institution.

Assessing mitral regurgitation

Dr. Martin shares his considerations for assessing mitral regurgitation.


Check our training programs, roundtable discussions, and education resources for the treatment of mitral and tricuspid diseases.

Global Grand Rounds

Grand Rounds are interactive global webcasts delivered by industry-leading experts on a wide range of relevant topics. Listen to Drs. Bavaria and Klautz discuss Today's SAVR Patient: Case Based Discussions Valve Design and Impact on Clinical Outcomes.

Featured products

Crescent™* RA Jugular Dual Lumen Catheter

Rediscover pediatric VV ECMO.
You spoke. We listened.

Only physicians with previous training and experience with venous catheterization and extracorporeal life support should use this device.

Avalus Bioprosthesis

A design platform for long-term durability. Interior-mounted leaflets that leverage our proprietary AOA™ tissue treatment.

No clinical data is available which evaluates the long-term impact of AOA treatment in patients.


Strong, proven hemodynamics1,2


Mitral repair/tricuspid repair

A complete portfolio of rigid, semi-rigid, and flexible annuloplasty products designed specifically for a more physiological mitral and tricuspid valve repair.

Valve replacement

Aortic, mitral, bovine, and porcine tissue; stented, stentless, and mechanical — we have a full portfolio to meet your needs.

CABG-enabling technologies

Beating heart procedures and sicker coronary patients — we can help you find the right procedure for the right patient.

Cardiopulmonary and blood management

Innovative and proven, a complete portfolio to optimize your circuit and blood product utilization.


Unmatched selection of cannulae — pediatric and adult — to facilitate insertion and drainage techniques.

Extracorporeal life support

Your mission is our mission — providing you with products designed for ECMO.

Surgical ablation

Achieve transmural lesions with temperature-controlled ablation systems.

Minimally invasive cardiac surgery

A video library of MICS techniques and approaches.

Equipment services and support

Maximum equipment UPTIME. You expect it, patients rely on it, and we deliver it.

News and stories


Medtronic has been committed to cannulae for 40 years

Stay up to date with physician experiences, patient stories, and much more.

Connect with us

Follow us on social media

Stay up to date with new products, innovative stories, and events:

Upcoming conferences

Sign up for updates

Get the latest cardiac surgery updates from Medtronic.

Contact information

CardioVascular LifeLine

Related pages

Education and training 

View our education and training materials for more information.

™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

Crescent™* RA jugular dual lumen catheter is manufactured by MC3, Inc. and exclusively distributed by Medtronic. Crescent™* RA jugular dual lumen catheters are not approved in every geography.



Tadokoro N, Fukushima S, Shimahara Y, et al. Comparison of safety and haemodynamic performance between the Avalus™ stented aortic valve bioprosthesis and Magna™ valve in Japanese patients. Gen Thorac Cardiovasc Surg. July 2021;69(7):1060-1069.


The latest results of the Perigon Study, presented by Prof. Dr. Robert J.M. Klautz during EACTS 2021: Surgical Aortic Valve Replacement with a Stented Pericardial Bioprosthesis: 5-year Outcomes. The PERIGON Pivotal Trial regarding the Avalus valve is a prospective, interventional, nonrandomized, worldwide, multi-site trial, with each center following a common protocol. The study was designed in accordance with the recommendations of the EN ISO 5840:2009 standard for cardiac valve prostheses and the U.S. Food and Drug Administration (FDA) Heart Valve Guidance (2010; DRAFT) and conducted in accordance with the Declaration of Helsinki and good clinical practice guidelines. Valve-related events and deaths were adjudicated by an independent clinical events committee (CEC). All study echocardiograms were analyzed by an independent core laboratory (MedStar Health Research Institute, Washington, D.C.). Safety oversight was provided by an independent data and safety monitoring board (DSMB). This trial is registered at, NCT02088554.